首頁 > 市場調查報告書 > 製藥

呼吸器

肺炎檢測市場規模、佔有率和成長分析（按產品類型、類型、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900217

肺炎檢測市場規模、佔有率和成長分析（按產品類型、類型、最終用戶和地區分類）－2026-2033年產業預測

Pneumonia Testing Market Size, Share, and Growth Analysis, By Product Type (Reagents & Consumables, Instruments), By type (Streptococcus-Based, Viral Pneumonia-Based), By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，肺炎檢測市場規模將達到 5.9659 億美元，到 2025 年將達到 6.3596 億美元，到 2033 年將達到 10.6045 億美元，預測期（2026-2033 年）的複合年成長率為 6.6%。

由於肺炎發病率上升和早期診斷技術的進步，肺炎檢測市場正經歷顯著成長。受疫情影響，病毒性肺炎病例激增，人們對肺炎檢測的關注度也隨之提高。雖然新冠肺炎帶來了新的肺炎風險，但封鎖措施卻意外地減少了本地傳播病例。技術進步，特別是核酸檢測技術的進步，以及政府和非政府組織為提高公眾意識和推廣正確診斷所做的努力，也推動了市場成長。貧窮問題導致發展中國家肺炎相關死亡率居高不下，促使各國政府實施旨在提高公眾意識和提升診斷能力的計畫。此外，已開發國家對肺炎檢測指南的遵循也可能進一步推動這個重要市場的成長。

肺炎檢測市場促進因素

全球肺炎檢測市場的主要促進因素之一是肺炎發病率的不斷上升，尤其是在嬰幼兒、老年人和免疫系統較弱等弱勢群體中。肺炎病例的增加推動了對精準診斷工具和檢測方案的需求，因為及時準確地識別疾病對於有效治療和管理至關重要。此外，醫療技術的進步，包括快速診斷測試和分子技術的開發，提高了快速診斷各種類型肺炎的能力。隨著醫療機構尋求更有效的方法來對抗這種感染疾病，這些技術創新進一步推動了市場成長。

肺炎檢測市場的限制

全球肺炎檢測市場的主要限制因素之一是先進診斷技術和設備的高成本。肺炎檢測的複雜性通常需要專門的實驗室和訓練有素的人員，這可能會限制其普及，尤其是在中低收入國家。此外，大眾對肺炎症狀缺乏認知和了解，可能導致診斷和後續檢測延誤，進一步阻礙市場成長。醫療機構面臨的預算限制也阻礙了創新檢測方案的採用，導致其依賴傳統方法，而這些方法在準確診斷肺炎方面可能效果不佳。

肺炎檢測市場趨勢

肺炎檢測市場正經歷一場由自動化和人工智慧融合驅動的變革。這些先進技術提高了檢測資料處理的速度和準確性，使醫療專業人員能夠更有效率、更自信地解讀結果。基於人工智慧的系統正被擴大用於最大限度地減少診斷中的人為錯誤，從而提高肺炎患者的護理標準。這種創新技術的整合不僅簡化了臨床工作流程，還支援更有效的治療通訊協定，使自動化和人工智慧驅動的解決方案成為肺炎調查方法發展的核心要素。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Quidel Corporation（US）
Becton, Dickinson, and Company（US）
Meridian Bioscience, Inc.（US）
Qiagen NV（Netherlands）
bioMerieux SA（France）
Bio-Rad Laboratories Inc.（US）
Cardinal Health Inc.（US）
Hologic Inc.（US）
La Roche Ltd.（Switzerland）
Abbott Laboratories（US）
Quest Diagnostics（US）
Luminex Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Agena Bioscience, Inc.（US）
Roche Diagnostics（Switzerland）
Grifols, SA（Spain）
PerkinElmer, Inc.（US）
Genoa Healthcare, LLC（US）
SeraCare Life Sciences, Inc.（US）
Randox Laboratories Ltd.（UK）
Acon Laboratories, Inc.（US）

簡介目錄

Product Code: SQMIG35D2250

Pneumonia Testing Market size was valued at USD 596.59 Million in 2024 and is poised to grow from USD 635.96 Million in 2025 to USD 1060.45 Million by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).

The pneumonia testing market is experiencing significant growth, driven by the increasing incidence and early diagnosis of the disease. The rise in viral pneumonia cases, exacerbated by the pandemic, has heightened awareness around pneumonia testing. While COVID-19 introduced additional pneumonia risks, lockdowns inadvertently led to decreased community-acquired cases. Advancements in technology, specifically nucleic acid detection, coupled with efforts from both governmental and non-governmental organizations to enhance awareness and promote proper diagnosis, are also propelling market growth. In less developed regions, poverty-related issues contribute to high pneumonia-related mortality rates, prompting governments to implement programs aimed at improving awareness and diagnostic capabilities. Moreover, adherence to pneumonia testing guidelines in developed nations is likely to foster further growth in this vital market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pneumonia Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pneumonia Testing Market Segments Analysis

Global Pneumonia Testing Market is segmented by Product Type, Type, End-user, and region. Based on Product Type, the market is segmented into Instruments, Reagents & Consumables. Based on Type, the market is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others. Based on End-user, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Pneumonia Testing Market

One key market driver for the global pneumonia testing market is the increasing prevalence of pneumonia, especially among vulnerable populations such as infants, the elderly, and individuals with compromised immune systems. This rise in pneumonia cases fuels the demand for accurate diagnostic tools and testing solutions, as timely and precise identification of the disease is critical for effective treatment and management. Additionally, advancements in medical technology, including the development of rapid diagnostic tests and molecular techniques, enhance the ability to quickly diagnose various pneumonia types, further supporting market growth as healthcare providers seek efficient methods to combat this infectious disease.

Restraints in the Pneumonia Testing Market

One significant market restraint for the global pneumonia testing market is the high cost associated with advanced diagnostic technologies and equipment. The complexity of pneumonia testing often requires specialized laboratories and trained personnel, which can limit accessibility, particularly in low- and middle-income countries. Additionally, the lack of awareness and understanding of pneumonia symptoms among the general population may lead to delayed diagnoses and subsequent testing, further hindering market growth. Budget constraints faced by healthcare facilities can also impede the adoption of innovative testing solutions, leading to reliance on traditional methods that may be less effective in accurately diagnosing pneumonia.

Market Trends of the Pneumonia Testing Market

The pneumonia testing market is witnessing a transformative trend driven by the integration of automation and artificial intelligence. These advanced technologies enhance the speed and accuracy of test data processing, allowing healthcare professionals to interpret results with greater efficiency and reliability. AI-based systems are increasingly being utilized to minimize human errors in diagnostics, thereby elevating the standard of care for pneumonia patients. This convergence of innovation not only streamlines workflows within clinical settings but also supports more effective treatment protocols, positioning automated and AI-driven solutions as pivotal components in the evolution of pneumonia testing methodologies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition
PESTEL Analysis

Pneumonia Testing Market by Product Type

Market Overview
Instruments
Reagents & Consumables

Pneumonia Testing Market by Type

Market Overview
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Others

Pneumonia Testing Market by End-user

Market Overview
Hospitals & Clinics
Diagnostic Centers
Others

Pneumonia Testing Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agena Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genoa Healthcare, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SeraCare Life Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments